Ovarian Cancer Diagnostic Market Size Report

Ovarian Cancer Diagnostic Market Size Analysis, Product Analysis, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2026

  • Published Date: ---
  • Base Year for Estimate: ---
  • Report ID: GVR6150
  • Format: Electronic (PDF)
  • Historical Data: ---
  • Number of Pages: 0

The global ovarian cancer diagnostic market is projected to exhibit moderate growth through the forecast period, driven by the high global disease burden and technological advancements. Proactive government initiatives and steady growth in consumer awareness are likely to promote higher growth in this market.

Ovarian cancer is a gynecologic cancer that begins in the ovaries and is frequently diagnosed at late stages, when cancer has metastasized. Risk factors for ovarian cancer include family history, age, postmenopausal hormone-replacement therapy, and lifestyle factors such as cigarette smoking & alcohol consumption. The exact cause of ovarian cancer is yet to be identified and additional research is required to understand the underlying molecular mechanism of this deadly disease.

The market is segmented by cancer types. Epithelial tumors account for nearly 90% of all ovarian cancer cases. Germ cell tumors and stromal cell tumors captured relatively minor market shares in 2018. The ovarian cancer diagnostic market is further segmented into imaging, blood tests, and biopsy - on the basis of diagnosis type.

Although ultrasound is the preliminary course of action in imaging ovarian cancer, the tool is not applicable in staging the disease. CT scan is the more preferred imaging tool for cancer staging. In addition, although CA125 is the mainstay in blood test biomarkers, increasing emphasis on genetic tests is driving the market for HER-2, BRCA, and KRAS mutations.

Geographically, the ovarian cancer diagnostic market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Some of the major players in the global ovarian cancer diagnostics market include F. Hoffmann-La Roche Ltd; GlaxoSmithKline plc; Johnson & Johnson Services, Inc.; AstraZeneca plc; Siemens Healthcare GmbH; Quest Diagnostics Incorporated; Thermo Fisher Scientific; Bio-Rad Technologies Inc; and Abbott.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified